newsfilter
← Latest News
GlobeNewswire·

Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close

Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercialization DALLAS, TX, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc.